Edition:
United States

AMAG Pharmaceuticals Inc (AMAG.OQ)

AMAG.OQ on NASDAQ Stock Exchange Global Select Market

20.65USD
21 Sep 2018
Change (% chg)

$-0.25 (-1.20%)
Prev Close
$20.90
Open
$20.90
Day's High
$21.27
Day's Low
$20.45
Volume
498,486
Avg. Vol
146,071
52-wk High
$26.08
52-wk Low
$11.93

Chart for

About

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia... (more)

Overall

Beta: 0.53
Market Cap(Mil.): $711.86
Shares Outstanding(Mil.): 34.47
Dividend: --
Yield (%): --

Financials

  AMAG.OQ Industry Sector
P/E (TTM): -- 30.48 32.69
EPS (TTM): -7.16 -- --
ROI: -14.24 13.04 12.72
ROE: -29.88 14.99 14.85

BRIEF-AMAG Pharmaceuticals Announces Q1 Loss Per Share $1.59

* AMAG PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RAISES FULL YEAR FINANCIAL GUIDANCE

May 03 2018

BRIEF-AMAG Pharmaceuticals Appoints J. Alan Butcher As Executive Vice President

* AMAG PHARMACEUTICALS APPOINTS J. ALAN BUTCHER AS EXECUTIVE VICE PRESIDENT AND CHIEF BUSINESS OFFICER Source text for Eikon: Further company coverage:

May 02 2018

BRIEF-AMAG Pharmaceuticals Submits NDA To FDA For Bremelanotide

* AMAG PHARMACEUTICALS SUBMITS A NEW DRUG APPLICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR BREMELANOTIDE FOR THE TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) IN PREMENOPAUSAL WOMEN Source text for Eikon: Further company coverage:

Mar 26 2018

Earnings vs. Estimates